Elliott Investment Management Drives Board Changes at Medtronic

Activist Investor Involvement

• 💡 Elliott Investment Management has become one of the largest shareholders in Medtronic, spurring significant changes.
• 🎯 Two new independent directors have been appointed to Medtronic's board, a move that aligns with investor expectations.

Medtronic's Performance and Investor Frustration

• 📈 Investors, including Elliott, have been frustrated with Medtronic's performance over the last decade, particularly a lack of EPS growth and margin improvement.
• ⚠️ Challenges in managing costs and navigating supply chain issues post-COVID have contributed to underperformance.
• 🚀 Medtronic is believed to be at an inflection point of growth, with new products expected to drive revenue and margin improvements.

Elliott's Strategy and Future Expectations

• 📌 Elliott's involvement appears to be a recent development, with the activist investor taking a significant position over the last quarter.
• 🤝 The interchange between Elliott and Medtronic seems to have been relatively friendly, resulting in board changes without a proxy fight.
• 🔑 The new directors are expected to hold management accountable for executing growth strategies and delivering on product launches.
• 📊 Elliott is known for its active campaigns and is not afraid to pursue board seats through votes, as seen in past involvements with companies like Phillips 66.